Amarin Corp Plc (AMRN)

[marzan]

You raise a lot of concerns, but I’m genuinely trying to understand your position here. If you believe the generics will simply backfill any gap, question the legal path, doubt the formulation strategy, and don’t see Europe accelerating—then what exactly is your investment thesis for holding Amarin Corporation shares right now?

At some point it’s a simple question: if the outlook is as limited as you describe, why stay invested? Are you expecting a legal win, a strategic shift, or something else to change the trajectory? Would be helpful to hear what keeps you in rather than just what could go wrong.